Search - tctmd.com

Displaying 801 - 820 of 2956

Sort: Relevancy | Date

Presentation TCT 2017

Transpericardial Access for LAA Closure

Presenter: Stefan C. Bertog, Apostolos Tzikas, Krzysztof Bartus

October 31, 2017

Presentation TCT 2017

Master Perspectives: Compared to Medical Therapy, Does CTO PCI Improve Prognosis, or Are the Main Benefits Symptomatic Improvement?

Presenter: Barry D. Rutherford, Robert W. Yeh

October 31, 2017

Presentation TCT 2017

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

Presenter: Michael J. Reardon

October 31, 2017

Presentation TCT 2017

Insights From the PLATINUM DIVERSITY Study

Presenter: Alice K. Jacobs, Spencer B. King III, Wayne B. Batchelor

October 31, 2017

Presentation TCT 2017

In Which Direction is Cell Based Heart Failure Therapy Headed?

Presenter: Francisco Fdez-Aviles, Emerson C. Perin

October 31, 2017

Presentation TCT 2017

How to Align Incentives in the Cath Lab

Presenter: Peter L Duffy, Hadley Wilson, Herbert D. Aronow

October 31, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Presentation TCT 2017

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program

Presenter: Farouc Jaffer, Ajay J. Kirtane, Nicholas J. Lembo

October 31, 2017

Presentation TCT 2017

Case Presentation: No Reflow After Primary PCI

Presenter: David P. Faxon, Robert S. Schwartz, Mohamed Abdel-Wahab

October 31, 2017

Presentation TCT 2017

Insights From the CABG Arms in EXCEL and NOBLE: What Met Expectations, What Didnt?

Presenter: Antonio Colombo, David E. Kandzari, John D. Puskas

October 31, 2017

Presentation TCT 2017

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, David W.M. Muller

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Presenter: Vladimir Dzavik, Navin K. Kapur, David A Baran

October 31, 2017

Presentation TCT 2017

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Presenter: Hemal Gada

October 31, 2017

Presentation TCT 2017

Case #4: Paravalvular Leak Closure Using a Multifunctional Occluder Device

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Richard Nicandro R Torres

October 31, 2017

Presentation TCT 2017

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Presenter: David P. Faxon, Robert S. Schwartz, Stefan K. James

October 31, 2017

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Presenter: Martin B. Leon, Changfu Wu, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

Trans-septal Puncture for LAA Closure Using TEE Guidance

Presenter: Stefan C. Bertog, Apostolos Tzikas, Jacqueline Saw

October 31, 2017

Presentation TCT 2017

Outcomes and Clinical Implications From EXPLORE

Presenter: Barry D. Rutherford, Robert W. Yeh, Jose P.S. Henriques

October 31, 2017

Presentation TCT 2017

Impact of Sex, Race, Socioeconomic Status, and Region/Country on Acute and Late PCI Outcomes

Presenter: Alice K. Jacobs, Spencer B. King III

October 31, 2017

Advertisement

Transpericardial Access for LAA Closure

Master Perspectives: Compared to Medical Therapy, Does CTO PCI Improve Prognosis, or Are the Main Benefits Symptomatic Improvement?

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

Insights From the PLATINUM DIVERSITY Study

In Which Direction is Cell Based Heart Failure Therapy Headed?

How to Align Incentives in the Cath Lab

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program

Case Presentation: No Reflow After Primary PCI

Insights From the CABG Arms in EXCEL and NOBLE: What Met Expectations, What Didnt?

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Acute Cardiogenic Shock: The Case for First-line Use of IABP

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Case #4: Paravalvular Leak Closure Using a Multifunctional Occluder Device

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Trans-septal Puncture for LAA Closure Using TEE Guidance

Outcomes and Clinical Implications From EXPLORE

Impact of Sex, Race, Socioeconomic Status, and Region/Country on Acute and Late PCI Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content